A detailed history of Boston Standard Wealth Management, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Boston Standard Wealth Management, LLC holds 15,165 shares of DNA stock, worth $143,460. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,165
Previous 606,634 97.5%
Holding current value
$143,460
Previous $203 Million 38.92%
% of portfolio
0.02%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$0.22 - $9.31 $130,123 - $5.51 Million
-591,469 Reduced 97.5%
15,165 $124 Million
Q2 2022

Jul 12, 2022

BUY
$2.2 - $4.2 $1.33 Million - $2.55 Million
606,634 New
606,634 $1.44 Billion

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Boston Standard Wealth Management, LLC Portfolio

Follow Boston Standard Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Standard Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Standard Wealth Management, LLC with notifications on news.